BG505 SOSIP.GT1.1 gp140 Vaccine - New - New |
International AIDS Vaccine Initiative (IAVI) |
January 2024 |
|
10-1074-LS(-J) - New - New |
Rockefeller University/Celldex Therapeutics |
December 2022 |
|
3BNC117-LS (-J) - New - New |
Rockefeller University/Celldex Therapeutics |
December 2022 |
|
3BNC117-LS (-J) - New - New |
Rockefeller University/Celldex Therapeutics |
January 2023 |
|
ID93 + GLA Adjuvant Vaccine |
AAHI |
January 2023 |
|
N332-GT5 gp140, Adjuvanted with SMNP |
DAIDS/NIAID/NIH |
June 2023 |
|
VRC-HIVMAB0115-00-AB (VRC01.23LS) |
VRC/NIAID |
August 2022 |
|
MTBVAC |
Biofabri |
January 2023 |
|
V3G CH848 Pr-NP1, Adjuvanted and V3G CH848 mRNA-Tr2 |
VRC/NIAID/NIH |
May 2023 |
|
HIV-1 Adenovirus Type 4-Vectored (A549 cells) Vaccines (Ad4-Env150KN and Ad4-Env145NFL) - New - New |
VRC/NIAID/NIH |
July 2021 |
|
16055 NFL Delta Gly4 Env Protein Trimer, Adjuvanted with 3M-052 AF + Alum - New - New |
DAIDS/NIAID/NIH |
December 2023 |
|
INO-6160 and INO-6172 |
DAIDS/NIAID/NIH |
January 2023 |
|
Vesatolimod (GS-9620) - New - New |
Gilead |
April 2023 |
|
MVA.tHIVconsv4 Vaccine |
University of Oxford |
May 2023 |
|
MVA.tHIVconsv3 Vaccine |
University of Oxford |
May 2023 |
|
ChAdOx1.tHIVconsv1 - New - New |
University of Oxford |
December 2023 |
|
ChAdOx1.HIVconsv62 |
University of Oxford |
April 2023 |
|
Selgantolimod (GS-9688) |
Gilead |
January 2023 |
|
VRC-HIVVCP0l 08-00-VP (FP8vl -rTTHC) |
VRC/NIAID/NIH |
February 2022 |
|
VRC-HIVRGP0106-00-VP (HIV-1 Trimer 6931 Vaccine) |
VRC/NIAID/NIH |
February 2022 |
|